RECOVER-VITAL: Why Paxlovid Was Destined to Fail Against Long COVID

The NIH Trial That Treated the Wrong Disease in the Wrong Patients While Ignoring the One Variable That Actually Matters

By Peter A. McCullough, MD, MPH

🦠 Wrong Patients, Wrong Drug, Wrong Outcomes

As a clinical trialist, I can tell you much is learned from neutral randomized trials such as this one. Major explanations fall into the categories of poorly selected patients, lack of an effective drug, and choosing the wrong clinical outcomes. Long-COVID occurs in unvaccinat…